Newscope Capital News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Advancing clinical development of gout drug Bucillamine for infectious diseases, including COVID-19 Developing novel psilocybin and cannabidiol therapeutics for central nervous system and inflammatory disorders Revive Therapeutics Ltd (CSE:RVV) (OTCMKTS:RVVTF) is a life sciences company focused on the research and development of drugs for infectious diseases as well as central nervous system and inflammatory disorders. Its cannabinoid pharmaceutical portfolio focuses on rare inflammatory areas such as liver disease. The company has been granted orphan drug status designation by the US Food...

Here is a summary of the latest leadership changes within the cannabis industry. Papa & Barkley Announces Promotions, New Hires Cannabis wellness company Papa & Barkley has boosted its executive team with several promotions and new hires. Adam Grossman, who served as founder and CEO of... Read More... Don't Miss Any Updates! News Directly in Your Inbox Subscribe to:

The Psilocybin Patent Race Is On It feels like these companies are casting a wide net, but it makes sense to file at the beginning of this mushroom mania. Mar 06, 2021 | 12:30 PM EST It seems that a week doesn't go by without a psychedelic company saying it has filed for a patent of some sort. This process can be confusing as the first assumption is that these companies are trying to patent a natural product. It isn't difficult to see how this misunderstanding happens. The headlines shout psychedelic company! Psilocybin! Patent! That, however, isn't exactly what is happening. Truth Be...

Inside of a Legal Psilocybin Wellness Retreat At Benzinga, we do what we say, and we say what we do. This hands-on mentality allowed me to take a week off to experience a legal psilocybin retreat in Jamaica. The active ingredient in “magic mushrooms” is currently being researched by top-tier institutions for the treatment of severe mental health conditions such as major depression, addiction, and end-of-life distress. Psilocybin can also be a great tool for wellbeing and human optimization. The wellness aspect of psilocybin treatment has recently opened the gates to "psychedelic tourism,"...

Life Sciences Company to Acquire Psychedelic Pharmaceutical Firm's Psilocybin Program News Update Streetwise Reports  (12/22/20) Revive Therapeutics reported it has submitted a non-binding letter of intent to acquire 100% of PharmaTher Inc.'s psilocybin program. In a news release, specialty life sciences companyRevive Therapeutics Ltd. (RVV:TSX.V; RVVTF:OTCMKTS), which focuses on developing therapeutics for infectious diseases and rare disorders, announced that it has executed a non-binding letter of intent (LOI) to acquire the full intellectual property (IP) rights pertaining to th...